01 1Taro Pharmaceutical Industries
01 1TAZAROTENE, MICRONIZED
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-01-05
Pay. Date : 2014-10-30
DMF Number : 28470
Submission : 2014-10-31
Status : Active
Type : II
20
Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TAZAROTENE, MICRONIZED, with a corresponding US DMF Number 28470.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 05, 2015, and payment made on October 30, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
